Speaker illustration

Doctor Ricky Turgeon

University of British Columbia, Vancouver (Canada)

Member of:

European Society of Cardiology

Dr. Turgeon’s research focuses on integrating high-quality observational studies and meta-analyses of clinical studies to guide the creation and evaluation of decision support tools and other knowledge translation strategies to ensure that pharmacotherapy for cardiovascular disease align with patient goals, preferences and values. His research is centered on implementation science, with a focus on antithrombotic agents, lipid-lowering therapies, pharmacotherapy for heart failure, and on the cardiovascular safety of medications.

Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic

Event: ESC Congress 2023

Topic: Advanced Clinical Practice

Session: Innovative models of cardiovascular care


Comparing dual antiplatelet therapy strategies post-acute coronary syndrome: network meta-analysis

Event: ESC Congress 2022

Topic: Antiplatelet Drugs

Session: Short and long-term antiplatelet therapy in clinical practice


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb